Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

We conducted an analysis of indirect costs alongside the LY.12 randomized trial in patients with relapsed or refractory (R/R) aggressive non-Hodgkin lymphoma (NHL). Lost productivity data for Canadian patients and caregivers in the trial were collected at baseline and with each chemotherapy cycle pr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anca Prica, Annette E. Hay, Michael Crump, Nicole Mittmann, Lois E. Shepherd, Ralph M. Meyer, Kevin I. Imrie, Nancy Risebrough, Marina Djurfeldt, Bingshu E. Chen, Matthew C. Cheung
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-03-01
Col·lecció:	Current Oncology
Matèries:	lymphoma autologous stem cell transplantation cost-effectiveness analysis
Accés en línia:	https://www.mdpi.com/1718-7729/28/2/119
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!